Mohammad Abdollahi

May 16, 2024 | thelancet.com | S List |Michael Brauer |Gregory A. Roth |Mohammad Abdollahi

SummaryUnderstanding the health consequences associated with exposure to risk factors is necessary to inform public health policy and practice.

Feb 23, 2024 | tandfonline.com | Mohammad Abdollahi

References Corsetti M, Whorwell P. Novel pharmacological therapies for irritable bowel syndrome. Expert review of gastroenterology & hepatology. Exp Rev Gastroenterol Hepatol. 2016;10(7):807–815. doi: 10.1586/17474124.2016.1158099 View PubMed Web of Science ®Google Scholar Deiana S, Gabbani T, Bagnoli S, et al. Emerging drug for diarrhea predominant irritable bowel syndrome. Expert Opin Emerg Drugs. 2015;20(2):247–261.

May 4, 2023 | tandfonline.com | Mohammad Abdollahi

ABSTRACTIntroduction Acute gastrointestinal cramping pain (GICP) is a debilitating condition that affects many people worldwide, significantly reducing their quality of life. As such, prompt treatment is crucial. Areas covered This article will explore relevant literature from respected databases such as PubMed, Scopus, Google Scholar, Cochrane Library, and Web of Science. Additionally, we searched ClinicalTrials.gov and the WHO ICTRP database for the latest clinical trials.